Michael Scolaro

Michael Scolaro

Oct 16, 2017

Group 6 Copy 155
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

How do you know a surgeon in training is ready to operate independently?

I am trying to find a cheap, easy and reliable way to grade the skill of surgeons in training. Experts can judge...

Does the Experience of Awe Predict Ketamine's Rapid Antidepressant Effect?

Ketamine is a very rapidly-acting and safe antidepressant medication given as an intravenous infusion, during...

Antibiotics and Affect: Avenues for Addiction Management

Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several decades...

Backer Badge Funded